These findings indicate the compromised binding of STAT3 and NF-κB p50 to the RANTES promoter in patients with HIES, and this compromised binding is attributed to the reduced pSTAT3 levels, which are acting as its own regulator. Here, NFKB1 is linked to hyper-IgE syndrome.